🇺🇸 Nebulized Salbutamol in United States
7 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 7
Most-reported reactions
- Drug Ineffective — 2 reports (28.57%)
- Asthma — 1 report (14.29%)
- Condition Aggravated — 1 report (14.29%)
- Fatigue — 1 report (14.29%)
- Hypercapnia — 1 report (14.29%)
- Respiratory Acidosis — 1 report (14.29%)
Other Respiratory approved in United States
Frequently asked questions
Is Nebulized Salbutamol approved in United States?
Nebulized Salbutamol does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Nebulized Salbutamol in United States?
Hospital General Naval de Alta Especialidad - Escuela Medico Naval is the originator. The local marketing authorisation holder may differ — check the official source linked above.